WallStSmart

JBS N.V. (JBS)vsJohn B Sanfilippo & Son Inc (JBSS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JBS N.V. generates 7655% more annual revenue ($91.17B vs $1.18B). JBSS leads profitability with a 5.3% profit margin vs 1.2%. JBS trades at a lower P/E of 12.5x. JBSS earns a higher WallStSmart Score of 51/100 (C-).

JBS

Hold

39

out of 100

Grade: F

Growth: 4.7Profit: 6.0Value: 6.0Quality: 6.0
Piotroski: 6/9Altman Z: 2.62

JBSS

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 4.7Quality: 7.5
Piotroski: 1/9Altman Z: 3.86
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for JBS.

JBSSSignificantly Overvalued (-53.3%)

Margin of Safety

-53.3%

Fair Value

$51.52

Current Price

$70.26

$18.74 premium

UndervaluedFair: $51.52Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JBS3 strengths · Avg: 8.7/10
Return on EquityProfitability
77.9%10/10

Every $100 of equity generates 78 in profit

P/E RatioValuation
12.5x8/10

Attractively priced relative to earnings

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

JBSS4 strengths · Avg: 8.8/10
Altman Z-ScoreHealth
3.8610/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.299/10

Conservative balance sheet, low leverage

P/E RatioValuation
14.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Areas to Watch

JBS4 concerns · Avg: 2.3/10
Profit MarginProfitability
1.2%3/10

1.2% margin — thin

Operating MarginProfitability
3.1%3/10

Operating margin of 3.1%

EPS GrowthGrowth
-57.2%2/10

Earnings declined 57.2%

Debt/EquityHealth
2.971/10

Elevated debt levels

JBSS4 concerns · Avg: 3.5/10
PEG RatioValuation
1.524/10

Expensive relative to growth rate

Revenue GrowthGrowth
4.2%4/10

4.2% revenue growth

Market CapQuality
$863.86M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.3%3/10

5.3% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : JBS

The strongest argument for JBS centers on Return on Equity, P/E Ratio, Price/Book. Revenue growth of 13.8% demonstrates continued momentum.

Bull Case : JBSS

The strongest argument for JBSS centers on Altman Z-Score, Debt/Equity, P/E Ratio.

Bear Case : JBS

The primary concerns for JBS are Profit Margin, Operating Margin, EPS Growth. Debt-to-equity of 2.97 is elevated, increasing financial risk. Thin 1.2% margins leave little buffer for downturns.

Bear Case : JBSS

The primary concerns for JBSS are PEG Ratio, Revenue Growth, Market Cap.

Key Dynamics to Monitor

JBS is growing revenue faster at 13.8% — sustainability is the question.

JBS generates stronger free cash flow (240M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

JBSS scores higher overall (51/100 vs 39/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JBS N.V.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.

John B Sanfilippo & Son Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

John B. Sanfilippo & Son, Inc., along with its subsidiary, JBSS Ventures, LLC, processes and distributes tree nuts and peanuts in the United States. The company is headquartered in Elgin, Illinois.

Want to dig deeper into these stocks?